| 1L | 2P | 3L | 5P | 6P | 7P | 8P | 9P | 10P | 1P | 2L | 3P | 5L | 6L | 7L | 8L | 9L | 10L |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tissue morphology | 68 | 65 | 62 | 71 | 50.5 | 40 | 52 | 52 | 60 | 88 | 88 | 84 | 82.5 | 45 | 39 | 55 | 80 | 65 |
Matrix staining | 79 | 53 | 55 | 75.5 | 32 | 59 | 34 | 47 | 25 | 90 | 89 | 90 | 94 | 30 | 59 | 61 | 68 | 45 |
Cell morphology | 80 | 55 | 80 | 70 | 26.5 | 75 | 36 | 54 | 52 | 84 | 79 | 86.5 | 91.5 | 44 | 56 | 61.5 | 62 | 57 |
Chondrocyte clustering | 40 | 48 | 55 | 65 | 56 | 62 | 60 | 55 | 65 | 45 | 50 | 65 | 55 | 52 | 55 | 52 | 55 | 56 |
Surface architecture | 90 | 79 | 78 | 51.5 | 79.5 | 96 | 79 | 89 | 79 | 96 | 89 | 88 | 81 | 81 | 82 | 90 | 96 | 90 |
Basal integration. | 90 | 88 | 89 | 75 | 77.5 | 85 | 82 | 73 | 82 | 95 | 95 | 94 | 85 | 81 | 84 | 92 | 91 | 85 |
Formation of tidemark | 25 | 24 | 30 | 36 | 18 | 22 | 21 | 25 | 21 | 35 | 44 | 42 | 44 | 20 | 34 | 30 | 44 | 38 |
Subchondral bone abnormalities | 84 | 55 | 89 | 48 | 47 | 70 | 90 | 65 | 88 | 93.5 | 95 | 95.5 | 89 | 76.5 | 65 | 91.5 | 95 | 96 |
Inflammation | 100 | 100 | 100 | 62.5 | 82 | 100 | 82 | 75 | 97 | 100 | 100 | 100 | 77 | 80.5 | 92 | 89 | 95 | 100 |
Abnormal calcification/ossification | 100 | 100 | 100 | 87 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Vascularization | 86 | 20 | 95 | 70 | 52 | 50 | 42 | 45 | 70 | 100 | 92.5 | 96 | 94 | 50 | 48 | 55 | 95 | 75 |
Superficial assessment | 81 | 60 | 72.5 | 70 | 45 | 72 | 62 | 62 | 80 | 92 | 91.5 | 91.5 | 91.5 | 38 | 67 | 60 | 72 | 75 |
Mid/deep zone assessment | 80 | 62 | 75 | 75.5 | 61 | 75 | 71 | 66 | 76 | 89 | 92 | 89 | 82 | 75 | 50 | 83 | 84 | 85 |
Overall assessment | 84 | 65 | 75 | 64 | 61 | 71 | 69 | 74 | 71 | 90 | 93 | 91.5 | 80 | 68 | 60 | 78 | 80 | 76 |
Scaffold with cellsâCELLS | Â | Â | Â | Â | Â | Â | Â | Â | Â | + | + | + | + | + | + | + | + | + |
Scaffold without cellsâCTRL | + | + | + | + | + | + | + | + | + | Â | Â | Â | Â | Â | Â | Â | Â | Â |